99 related articles for article (PubMed ID: 26548572)
1. The chemopreventive activity of butyrate-containing structured lipids in experimental rat hepatocarcinogenesis.
Heidor R; de Conti A; Ortega JF; Furtado KS; Silva RC; Tavares PE; Purgatto E; Ract JN; de Paiva SA; Gioielli LA; Pogribny IP; Moreno FS
Mol Nutr Food Res; 2016 Feb; 60(2):420-9. PubMed ID: 26548572
[TBL] [Abstract][Full Text] [Related]
2. The chemopreventive activity of the butyric acid prodrug tributyrin in experimental rat hepatocarcinogenesis is associated with p53 acetylation and activation of the p53 apoptotic signaling pathway.
de Conti A; Tryndyak V; Koturbash I; Heidor R; Kuroiwa-Trzmielina J; Ong TP; Beland FA; Moreno FS; Pogribny IP
Carcinogenesis; 2013 Aug; 34(8):1900-6. PubMed ID: 23568954
[TBL] [Abstract][Full Text] [Related]
3. Chemopreventive effects of the dietary histone deacetylase inhibitor tributyrin alone or in combination with vitamin A during the promotion phase of rat hepatocarcinogenesis.
de Conti A; Kuroiwa-Trzmielina J; Horst MA; Bassoli BK; Chagas CE; Purgatto E; Cavalher FP; Camargo AA; Jordão AA; Vannucchi H; Scolastici C; Ong TP; Moreno FS
J Nutr Biochem; 2012 Aug; 23(8):860-6. PubMed ID: 21940155
[TBL] [Abstract][Full Text] [Related]
4. Butyrate-containing structured lipids act on HDAC4, HDAC6, DNA damage and telomerase activity during promotion of experimental hepatocarcinogenesis.
Festa Ortega JF; Heidor R; Auriemo AP; Marques Affonso J; Pereira D' Amico T; Herz C; de Conti A; Ract J; Gioieli LA; Purgatto E; Lamy E; P Pogribny I; Salvador Moreno F
Carcinogenesis; 2021 Aug; 42(8):1026-1036. PubMed ID: 33999989
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention of rat hepatocarcinogenesis with histone deacetylase inhibitors: efficacy of tributyrin, a butyric acid prodrug.
Kuroiwa-Trzmielina J; de Conti A; Scolastici C; Pereira D; Horst MA; Purgatto E; Ong TP; Moreno FS
Int J Cancer; 2009 Jun; 124(11):2520-7. PubMed ID: 19195022
[TBL] [Abstract][Full Text] [Related]
6. Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein.
Ortega JF; de Conti A; Tryndyak V; Furtado KS; Heidor R; Horst MA; Fernandes LH; Tavares PE; Pogribna M; Shpyleva S; Beland FA; Pogribny IP; Moreno FS
Oncotarget; 2016 Apr; 7(17):24339-47. PubMed ID: 27013579
[TBL] [Abstract][Full Text] [Related]
7. Butyrate-containing structured lipids inhibit RAC1 and epithelial-to-mesenchymal transition markers: a chemopreventive mechanism against hepatocarcinogenesis.
de Conti A; Tryndyak V; Heidor R; Jimenez L; Moreno FS; Beland FA; Rusyn I; Pogribny IP
J Nutr Biochem; 2020 Dec; 86():108496. PubMed ID: 32920087
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic effects of the chemopreventive agent tributyrin, a butyric acid prodrug, during the promotion phase of hepatocarcinogenesis.
Andrade FO; Furtado KS; Heidor R; Sandri S; Hebeda CB; Miranda MLP; Fernandes LHG; Yamamoto RC; Horst MA; Farsky SHP; Moreno FS
Carcinogenesis; 2019 Aug; 40(8):979-988. PubMed ID: 30590392
[TBL] [Abstract][Full Text] [Related]
9. Geranylgeraniol and beta-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-kappaB activation.
de Moura Espíndola R; Mazzantini RP; Ong TP; de Conti A; Heidor R; Moreno FS
Carcinogenesis; 2005 Jun; 26(6):1091-9. PubMed ID: 15718255
[TBL] [Abstract][Full Text] [Related]
10. The chemopreventive capacity of quercetin to induce programmed cell death in hepatocarcinogenesis.
Vásquez-Garzón VR; Macias-Pérez JR; Jiménez-García MN; Villegas V; Fattel-Fazenta S; Villa-Treviño S
Toxicol Pathol; 2013 Aug; 41(6):857-65. PubMed ID: 23197198
[TBL] [Abstract][Full Text] [Related]
11. The chemopreventive activity of the histone deacetylase inhibitor tributyrin in colon carcinogenesis involves the induction of apoptosis and reduction of DNA damage.
Heidor R; Furtado KS; Ortega JF; de Oliveira TF; Tavares PE; Vieira A; Miranda ML; Purgatto E; Moreno FS
Toxicol Appl Pharmacol; 2014 Apr; 276(2):129-35. PubMed ID: 24576724
[TBL] [Abstract][Full Text] [Related]
12. Chrysin abrogates early hepatocarcinogenesis and induces apoptosis in N-nitrosodiethylamine-induced preneoplastic nodules in rats.
Khan MS; Devaraj H; Devaraj N
Toxicol Appl Pharmacol; 2011 Feb; 251(1):85-94. PubMed ID: 21167192
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomic responses provide a new mechanistic basis for the chemopreventive effects of folic acid and tributyrin in rat liver carcinogenesis.
Guariento AH; Furtado KS; de Conti A; Campos A; Purgatto E; Carrilho J; Shinohara EM; Tryndyak V; Han T; Fuscoe JC; Ross SA; Beland FA; Pogribny IP; Moreno FS
Int J Cancer; 2014 Jul; 135(1):7-18. PubMed ID: 24302446
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis.
Bishayee A; Dhir N
Chem Biol Interact; 2009 May; 179(2-3):131-44. PubMed ID: 19073162
[TBL] [Abstract][Full Text] [Related]
15. All-trans and 9-cis retinoic acids, retinol and beta-carotene chemopreventive activities during the initial phases of hepatocarcinogenesis involve distinct actions on glutathione S-transferase positive preneoplastic lesions remodeling and DNA damage.
de Almeida Vasconcelos Fonseca EM; Chagas CE; Mazzantini RP; Heidor R; Ong TP; Moreno FS
Carcinogenesis; 2005 Nov; 26(11):1940-6. PubMed ID: 15975960
[TBL] [Abstract][Full Text] [Related]
16. Effect of Solanum trilobatum on the antioxidant status during diethyl nitrosamine induced and phenobarbital promoted hepatocarcinogenesis in rat.
Shahjahan M; Vani G; Shyamaladevi CS
Chem Biol Interact; 2005 Oct; 156(2-3):113-23. PubMed ID: 16188247
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation during early hepatocarcinogenesis: cellular and molecular effects.
Chagas CE; Bassoli BK; de Souza CA; Deminice R; Jordão Júnior AA; Paiva SA; Dagli ML; Ong TP; Moreno FS
Int J Cancer; 2011 Nov; 129(9):2073-82. PubMed ID: 21480218
[TBL] [Abstract][Full Text] [Related]
18. Genomic abnormalities in hepatocarcinogenesis. Implications for a chemopreventive strategy.
Pascale RM; Simile MM; Feo F
Anticancer Res; 1993; 13(5A):1341-56. PubMed ID: 8239505
[TBL] [Abstract][Full Text] [Related]
19. Post-initiation modulating effects of allyl sulfides in rat hepatocarcinogenesis.
Guyonnet D; Bergès R; Siess MH; Pinnert MF; Chagnon MC; Suschetet M; Le Bon AM
Food Chem Toxicol; 2004 Sep; 42(9):1479-85. PubMed ID: 15234078
[TBL] [Abstract][Full Text] [Related]
20. Review: Exploring anticarcinogenic agents in a rat hepatocarcinogenesis model--focus on selenium and statins.
Björkhem-Bergman L; Ekström L; Eriksson LC
In Vivo; 2012; 26(4):527-35. PubMed ID: 22773564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
